Nanomaterials for Pharmaceutical Applications

SINGH, SUNDAR; Tiwari, Sanjay; Tyagi, Sanjeev

doi:10.1007/978-981-15-9904-0_8

Cited by 1 publication

(1 citation statement)

References 69 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In addition to the Intaxel ® commercial formulation results, the PTX-laden NLCs benefit from its buildup and permanence in plasma. To achieve the dual treatment for HepG2 cells ( 166 ), a device containing sorafenib and SPIONs coloaded in SLNs has also been created.…”

Section: Applications Of Lbnps In Cancer Therapymentioning

confidence: 99%

Lipid-based nanoparticles as drug delivery carriers for cancer therapy

Waheed,

Ali,

Tabassum

et al. 2024

Front. Oncol.

View full text Add to dashboard Cite

Cancer is a severe disease that results in death in all countries of the world. A nano-based drug delivery approach is the best alternative, directly targeting cancer tumor cells with improved drug cellular uptake. Different types of nanoparticle-based drug carriers are advanced for the treatment of cancer, and to increase the therapeutic effectiveness and safety of cancer therapy, many substances have been looked into as drug carriers. Lipid-based nanoparticles (LBNPs) have significantly attracted interest recently. These natural biomolecules that alternate to other polymers are frequently recycled in medicine due to their amphipathic properties. Lipid nanoparticles typically provide a variety of benefits, including biocompatibility and biodegradability. This review covers different classes of LBNPs, including their characterization and different synthesis technologies. This review discusses the most significant advancements in lipid nanoparticle technology and their use in medicine administration. Moreover, the review also emphasized the applications of lipid nanoparticles that are used in different cancer treatment types.

show abstract

Section: Applications Of Lbnps In Cancer Therapymentioning

confidence: 99%